COSENTYX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug COSENTYX contains one active pharmaceutical ingredient (API):

1 Secukinumab UNII DLG4EML025 - SECUKINUMAB

Secukinumab is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralises the proinflammatory cytokine interleukin-17A (IL-17A). Secukinumab works by targeting IL-17A and inhibiting its interaction with the IL-17 receptor, which is expressed on various cell types including keratinocytes. As a result, secukinumab inhibits the release of proinflammatory cytokines, chemokines and mediators of tissue damage and reduces IL-17A-mediated contributions to autoimmune and inflammatory diseases. Read about Secukinumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COSENTYX Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AC10	Secukinumab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10425Q, 10494H, 10890E, 10893H, 10894J, 10895K, 10898N, 10899P, 10900Q, 10901R, 10906B, 10910F, 12297F, 12307R, 12321L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526516050085902, 526516050086002, 526516050086102, 526516050086202, 526516050086302, 526521060098603
Country: CA	Health Products and Food Branch	Identifier(s): 02438070
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 30-MBE-1015, 34-MBE-1115
Country: EE	Ravimiamet	Identifier(s): 1675616, 1675627, 1675638, 1675649, 1675650, 1704912, 1704923, 1833948, 1833959, 1833960, 1833982, 1857034, 1857045
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114980003, 114980004, 114980005, 114980010
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 156439, 445576, 478929, 555196
Country: FR	Base de données publique des médicaments	Identifier(s): 63549069, 65007804
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 292126, 348713, 393239
Country: HK	Department of Health Drug Office	Identifier(s): 64235, 64237, 64238, 67151, 67152
Country: IE	Health Products Regulatory Authority	Identifier(s): 88096, 88172, 89092
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7754, 7755, 9322, 9323
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999439G2028, 3999439G3024, 3999439G4020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075453, 1075454, 1075455, 1075456, 1075457, 1076650, 1076651, 1091485, 1091486, 1091487, 1091488, 1092976, 1092977
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 124397, 124400
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17618, 17619
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100333193, 100333224, 100444946, 100467410
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64460001, W64460002, W67058001, W67211001, W67964001
Country: SG	Health Sciences Authority	Identifier(s): 14749P, 14750P, 14751P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12433111H, 12433112H
Country: US	FDA, National Drug Code	Identifier(s): 0078-0639
Country: ZA	Health Products Regulatory Authority	Identifier(s): 49/30.1/0232, 49/30.1/0233